2024-11-13 - Analysis Report
## Teladoc Health Inc (TDOC) Stock Analysis

**1. Performance Analysis**

Teladoc Health Inc. (TDOC) is a virtual healthcare company that provides telehealth services. 

The table below presents the cumulative return of TDOC compared to the S&P 500 (VOO) over different periods.

| Year       | TDOC CAGR | VOO CAGR | CAGR Difference | Max CAGR Difference | Min CAGR Difference | Relative CAGR Difference |
|------------|------------|------------|-------------------|---------------------|-----------------------|---------------------------|
| 2015-2017  | 83.4%     | 18.2%     | 65.2%           | 531.09%               | -124.85%                | 0.41                      |
| 2016-2018  | 175.5%    | 27.8%     | 147.7%          | 531.09%               | -124.85%                | 0.91                      |
| 2017-2019  | 407.4%    | 31.5%     | 375.9%          | 531.09%               | -124.85%                | 2.49                      |
| 2018-2020  | 452.4%    | 18.4%     | 434.0%          | 531.09%               | -124.85%                | 2.86                      |
| 2019-2021  | 90.6%     | 30.5%     | 60.1%           | 531.09%               | -124.85%                | 0.47                      |
| 2020-2022  | -71.6%    | 26.9%     | -98.5%          | 531.09%               | -124.85%                | 0.09                      |
| 2021-2023  | -89.3%    | 18.9%     | -108.2%         | 531.09%               | -124.85%                | 0.03                      |
| 2022-2024  | -89.8%    | 13.9%     | -103.7%         | 531.09%               | -124.85%                | 0.05                      |

**TDOC's cumulative return is significantly lower than the S&P 500's, indicating a significant underperformance. The relative CAGR difference of 0.05 indicates TDOC is currently underperforming the S&P 500, but it has performed better in some periods in the past.**

**Alpha and Beta Analysis**
The provided data indicates that TDOC has experienced significant volatility, with both high alpha and beta values. This suggests that TDOC has historically been a riskier investment with the potential for both significant gains and losses.

**2. Recent Price Movements**
|  | Value |
|---|-------|
| Closing Price | 9.73  |
| 5-Day Moving Average | 9.54  |
| 20-Day Moving Average | 9.21  |
| 60-Day Moving Average | 8.53  |

**TDOC's price is currently above its moving averages, suggesting potential upward momentum.**

**3. Technical Indicators**
* **RSI:** 65.76 -  This indicates that TDOC is currently in overbought territory, suggesting that a correction might be possible in the near term. 
* **PPO:** 0.53 - This suggests that TDOC is experiencing bullish momentum.
* **Delta_Previous_Relative_Divergence:** -0.28 (-) - This indicates a short-term downward trend.
* **Expected Return:** 0.0% - This suggests that TDOC is not expected to outperform the S&P 500 over the long term (2 years or more).


**4. Recent Earnings and Outlook**

| Date       | EPS      | Revenue  |
|------------|----------|----------|
| 2024-10-31 | -0.19    | 0.64 B$  |
| 2024-08-01 | -4.92    | 0.64 B$  |
| 2024-04-26 | -0.49    | 0.65 B$  |
| 2023-10-27 | -0.35    | 0.66 B$  |
| 2024-10-31 | -0.35    | 0.66 B$  |

**TDOC has experienced a recent decline in earnings per share, and revenue growth appears to be stagnant. This indicates that TDOC is currently struggling to meet its financial targets.** 

**5. Financial Information Analysis**

**1) Revenue and Profitability**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2024-09-30 | $0.64B  | 71.94%       |
| 2024-06-30 | $0.64B  | 70.73%       |
| 2024-03-31 | $0.65B  | 69.89%       |
| 2023-12-31 | $0.66B  | 70.72%       |
| 2023-09-30 | $0.66B  | 71.83%       |

**TDOC maintains a strong profit margin, indicating efficient operations and good cost management.**

**2) Capital and Profitability**

| Quarter      | Equity     | ROE       |
|--------------|------------|-----------|
| 2024-09-30 | $1.51B    | -2.21%    |
| 2024-06-30 | $1.50B    | -55.77%   |
| 2024-03-31 | $2.29B    | -3.58%    |
| 2023-12-31 | $2.33B    | -1.24%    |
| 2023-09-30 | $2.29B    | -2.49%    |

**The negative ROE highlights that the company is currently not generating a positive return on its equity, indicating a challenge in profitability.**

**6. News and Recent Issues**

* **Recent Earnings News:** TDOC reported its Q3 2024 earnings on 10/31/2024, showing a decline in EPS and stagnant revenue growth. The company highlighted ongoing cost-cutting measures and a focus on improving profitability.
* **Analyst Opinions and Performance Highlights:** Finbold reported that several analysts downgraded TDOC, expressing concerns about the company's growth prospects and profitability. 

**7. Comprehensive Analysis**

TDOC is currently facing several challenges, including declining earnings, stagnant revenue, and a negative ROE. The company's focus on cost-cutting and improving profitability might provide a positive outlook for the future, but the market sentiment remains cautious. Technical indicators suggest potential upward momentum in the short term, but overall, TDOC is a risky investment with limited growth potential. 

**8. Report Summary**

Teladoc Health Inc. (TDOC) is a telehealth company currently facing significant challenges. Its performance is lagging behind the S&P 500, and its recent earnings report shows declining EPS and stagnant revenue growth. Although the company is taking steps to improve profitability, market sentiment remains cautious. While technical indicators suggest some short-term upward momentum, overall, TDOC is a risky investment with limited growth potential. 
